synchrogenix.com

Additionally, the MoH released a new procedure for the disclosure of both pre-clinical and clinical data disclosure. Under this law, the MoH is required to publish pre-clinical and clinical reports for all medicines on a public facing portal. During the registration of the dossier, MoH requires sponsors to submit pre-clinical and clinical data in pre-defined forms with a cover letter that has been developed by the authority. Based on years of experience ensuring sponsors maintain compliance through consulting, project leadership, remediation plan preparation, postings updates and completion, and process creation, we suggest the following in order to adhere to MoH Order 1528.

Nirpal Virdee, Synchrogenix’s Global Head of Transparency and Disclosure recently sat down with Trishna Bharadia, award-winning health advocate and patient engagement champion, for a discussion around patient engagement and patient centricity. Although there has been a surge in movement around patient advocacy, are pharma companies treating patients with the respect they deserve or continuing to lump all patients together? Expert patients are knowledgeable about their own experience with their condition, but also the experiences and issues affecting other patients within that condition community. Pro patients are advocates who have looked beyond their own disease area and are highly knowledgeable about not just their disease area, but also the issues that affect across lots of different patient communities, such as health literacy, use of technology within healthcare, patient engagement, and engaging with hard to reach communities.

Patient Engagement and Patient Centricity Series Part III: Engaging with The Right Patients for the Right Purpose Nirpal Virdee, Synchrogenix’s Global Head of Transparency and Disclosure recently sat down with Trishna Bharadia, award-winning health advocate and patient engagement champion, for a discussion around patient engagement and patient centricity. Click here to read Part II: Types of Patient Advocates So far in our Patient Engagement series, we have defined and explained the difference between Patient Engagement and Patient Centricity and examined the three different types of Patient Advocates. Unless industry recognizes that there are different types of patients suitable for different purposes, they’re not going to be engaging with the correct group,” she said. All these things need to be taken in to account when engaging with patients, which is why it is so important to recognize the different types of patient advocates and engage with them appropriately.

Nirpal Virdee, Synchrogenix’s Global Head of Transparency and Disclosure recently sat down with Trishna Bharadia, award-winning health advocate and patient engagement champion, for a discussion around patient engagement and patient centricity. According to Trishna, patient engagement and patient centricity are different. According to Trishna, patient engagement is about engaging with patients at the right time, in the appropriate manner, when it’s relevant. Click here to read Part II of our Patient Engagement and Patient Centricity Series where Trishna and Nirpal discuss the three different types of patient advocates .